Results 101 to 110 of about 173,777 (119)

Relationship Between Anti-GBM Antibodies and Kidney Outcomes in Patients With Anti-GBM Disease

Journal of Nephrology, 2023
Mengyue Zhu
exaly  

Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities

AAPS PharmSciTech, 2023
Umesh Gupta, Rakesh Kumar Sahoo, Akash Chaurasiya   +2 more
exaly  

Comparison of Glioblastoma (GBM) Molecular Classification Methods

Seminars in Cancer Biology, 2018
Eunjee Lee, Patrick J Paddison, Raymund L Yong   +2 more
exaly  

Clinical Features and Outcome of Patients With Both ANCA and Anti-GBM Antibodies

Kidney International, 2004
Charles D Pusey
exaly  

Dual Blockage of STAT3 and ERK1/2 Eliminates Radioresistant GBM Cells

Redox Biology, 2019
Wenwu Xiao, Lunquan Sun, Bowen Xie
exaly  

Treatment of Glioblastoma (GBM) With the Addition of Tumor-Treating Fields (TTF): A Review

Cancers, 2019
Pierre Giglio, Vinay K Puduvalli, Iyad Alnahhas   +2 more
exaly  

Diagnosis and Classification of Goodpasture's Disease (Anti-GBM)

Journal of Autoimmunity, 2014
Mårten Segelmark, Thomas Hellmark
exaly  

Clinical and Immunological Evolution of Oligoanuric Anti-GBM Nephritis Treated by Haemodialysis.

Lancet, The, 1986
C S Ogg, D G Williams, D G Williams
exaly  

Current Status and Future Therapeutic Perspectives of Glioblastoma Multiforme (GBM) Therapy: A Review

Biomedicine and Pharmacotherapy, 2017
Syed Shams Ul Hassan, Komal Anjum, Najeeb Akhter   +2 more
exaly  

Liposomal TriCurin, a Synergistic Combination of Curcumin, Epicatechin Gallate and Resveratrol, Repolarizes Tumor-Associated Microglia/Macrophages, and Eliminates Glioblastoma (GBM) and GBM Stem Cells

Molecules, 2018
Probal Banerjee, Sumit Mukherjee, Shuiqin Zhou   +2 more
exaly